Acadia Pharmaceuticals (ACAD) Other Gross PP&E Adjustments: 2009-2025
Historic Other Gross PP&E Adjustments for Acadia Pharmaceuticals (ACAD) over the last 12 years, with Sep 2025 value amounting to -$79.5 million.
- Acadia Pharmaceuticals' Other Gross PP&E Adjustments fell 9.13% to -$79.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$295.9 million, marking a year-over-year increase of 5.17%. This contributed to the annual value of -$59.6 million for FY2024, which is 32.85% up from last year.
- Per Acadia Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at -$79.5 million for Q3 2025, which was up 1.89% from -$81.0 million recorded in Q2 2025.
- In the past 5 years, Acadia Pharmaceuticals' Other Gross PP&E Adjustments registered a high of -$59.6 million during Q4 2024, and its lowest value of -$95.2 million during Q4 2021.
- In the last 3 years, Acadia Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$74.0 million in 2024 and averaged -$73.3 million.
- Per our database at Business Quant, Acadia Pharmaceuticals' Other Gross PP&E Adjustments tumbled by 181.27% in 2021 and then spiked by 32.85% in 2024.
- Quarterly analysis of 5 years shows Acadia Pharmaceuticals' Other Gross PP&E Adjustments stood at -$95.2 million in 2021, then rose by 2.20% to -$93.1 million in 2022, then rose by 4.73% to -$88.7 million in 2023, then skyrocketed by 32.85% to -$59.6 million in 2024, then fell by 9.13% to -$79.5 million in 2025.
- Its last three reported values are -$79.5 million in Q3 2025, -$81.0 million for Q2 2025, and -$75.8 million during Q1 2025.